UroGen Pharma Ltd. (URGN) Insider Trading -- Recent Executive & Director Transactions
8 insiders reported 46 Form 4 transactions for UroGen Pharma Ltd. (URGN) over the past 18 months (most recent 2026-10-09). Recent activity: Degnan Chris (Chief Financial Officer) Buy 4,483 shares, Degnan Chris (Chief Financial Officer) Sell 2,202 shares, Schoenberg Mark (Chief Medical Officer) Sell 871 shares, Smith Jason Drew (General Counsel) Buy 3,334 shares, Schoenberg Mark (Chief Medical Officer) Buy 1,667 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-09 | Degnan Chris | Chief Financial Officer | Buy | 4,483 | $0 |
| 2026-10-09 | Degnan Chris | Chief Financial Officer | Sell | 2,202 | $80,791 |
| 2026-09-09 | Schoenberg Mark | Chief Medical Officer | Sell | 871 | $37,383 |
| 2026-09-09 | Smith Jason Drew | General Counsel | Buy | 3,334 | $0 |
| 2026-09-09 | Schoenberg Mark | Chief Medical Officer | Buy | 1,667 | $0 |
| 2026-09-09 | Smith Jason Drew | General Counsel | Sell | 1,519 | $64,618 |
| 2026-08-28 | Robinson James A. Jr. | Director | Buy | 2,000 | $0 |
| 2026-08-24 | Schoenberg Mark | Chief Medical Officer | Sell | 60,677 | $2.9M |
| 2026-07-10 | Schoenberg Mark | Chief Medical Officer | Sell | 10,000 | $400,000 |
| 2026-06-24 | Schoenberg Mark | Chief Medical Officer | Sell | 10,000 | $350,100 |
| 2026-06-09 | Schoenberg Mark | Chief Medical Officer | Buy | 10,000 | $0 |
| 2026-06-09 | Schoenberg Mark | Chief Medical Officer | Sell | 5,222 | $142,561 |
| 2026-05-27 | Robinson James A. Jr. | Director | Buy | 2,000 | $0 |
| 2026-05-11 | Schoenberg Mark | Chief Medical Officer | Sell | 10,000 | $300,000 |
| 2026-02-27 | Robinson James A. Jr. | Director | Buy | 2,000 | $0 |
| 2026-02-11 | Smith Jason Drew | General Counsel | Buy | 5,500 | $0 |
| 2026-02-11 | Smith Jason Drew | General Counsel | Sell | 2,654 | $52,257 |
| 2026-02-11 | Smith Jason Drew | General Counsel | Buy | 3,333 | $0 |
| 2026-02-11 | Smith Jason Drew | General Counsel | Sell | 1,608 | $31,662 |
| 2026-02-11 | Smith Jason Drew | General Counsel | Buy | 6,667 | $0 |
| 2026-02-11 | Smith Jason Drew | General Counsel | Sell | 3,217 | $63,343 |
| 2026-02-04 | Schoenberg Mark | Chief Medical Officer | Sell | 1,844 | $36,308 |
| 2026-02-04 | Schoenberg Mark | Chief Medical Officer | Sell | 1,843 | $36,289 |
| 2026-02-04 | Schoenberg Mark | Chief Medical Officer | Sell | 3,686 | $72,577 |
| 2026-02-03 | Schoenberg Mark | Chief Medical Officer | Buy | 3,333 | $0 |
Source: SEC Form 4 filings · as of 2026-10-09